Advancing Enrollment and Reducing Drug Costs Act of 2023

Hozzl · 2024-12-19T09:07:04Z

Explore the details of House Bill 5384 Advancing Enrollment and Reducing Drug Costs Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/19/2024, 9:07 AM

Summary of Bill HR 5384

Bill 118 HR 5384, also known as the Advancing Enrollment and Reducing Drug Costs Act of 2023, aims to address the rising costs of prescription drugs and improve access to affordable healthcare for Americans. The bill focuses on two main areas: increasing enrollment in healthcare programs and reducing the costs of prescription drugs.

One key provision of the bill is the expansion of enrollment in Medicaid and the Children's Health Insurance Program (CHIP). This would allow more low-income individuals and families to access essential healthcare services at a lower cost. The bill also includes measures to streamline the enrollment process and make it easier for eligible individuals to sign up for these programs.

In addition to expanding enrollment, the bill also seeks to reduce the costs of prescription drugs. This includes measures to increase transparency in drug pricing, promote the use of generic medications, and allow for the importation of lower-cost prescription drugs from other countries. The bill also includes provisions to address price gouging by pharmaceutical companies and ensure that drug prices are fair and reasonable. Overall, the Advancing Enrollment and Reducing Drug Costs Act of 2023 aims to make healthcare more affordable and accessible for all Americans. By increasing enrollment in healthcare programs and reducing the costs of prescription drugs, the bill seeks to improve the overall health and well-being of the population.

Congressional Summary of HR 5384

Advancing Enrollment and Reducing Drug Costs Act of 2023

This bill specifies that certain Medicaid enrollees automatically qualify for low-income subsidies under the Medicare prescription drug benefit. Specifically, the bill automatically qualifies individuals who were enrolled in Medicaid before they turned 65 (as part of Medicaid expansion under the Patient Protection and Affordable Care Act) and whose income is below 200% of the federal poverty line.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5384

Bill HR 5384 is currently in the status of Bill Introduced since September 12, 2023. Bill HR 5384 was introduced during Congress 118 and was introduced to the House on September 12, 2023. Bill HR 5384's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5384

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5384

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5384

Advancing Enrollment and Reducing Drug Costs Act of 2023

To amend title XVIII of the Social Security Act to provide for the automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program, and for other purposes.